Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5471 Target Snapshot

Beta-1 adrenergic receptor · SINGLE PROTEIN · Cavia porcellus

545Compounds
169Assays
19Approved Drugs
453.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt B0FL73. Use UniProt B0FL73 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt B0FL73 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-1 adrenergic receptor as ChEMBL target CHEMBL5471, mapped to UniProt B0FL73. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-1 adrenergic receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-14
ChEMBL target ID
CHEMBL5471
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
B0FL73
Beta-1 adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-1 adrenergic receptor is the right protein anchor across sources, using UniProt B0FL73 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-1 adrenergic receptor
UniProt AccessionB0FL73
Component TypeProtein
Sequence Length467 aa

Beta-1 adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-1 adrenergic receptor, mapped to UniProt B0FL73. Sequence length is 467 aa.

Mapped IDB0FL73
Review nameBeta-1 adrenergic receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

19
Approved
5
Phase II
Assay Mix

Activity Type Distribution

IC5039.0
KI27.0
EC5048.0
KD339.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL443435 10.4 EC50 0.03981 Preclinical
CHEMBL30622 10.0 Kd 0.1 Preclinical
CHEMBL304344 9.82 Kd 0.1514 Preclinical
CHEMBL1256786 9.5 EC50 0.3162 Approved
CHEMBL499 9.44 Kd 0.3631 Approved
CHEMBL483200 9.1 EC50 0.7943 Preclinical
CHEMBL11671 9.07 Kd 0.8511 Preclinical
CHEMBL173424 9.07 Kd 0.8511 Preclinical
CHEMBL1788320 9.07 Kd 0.8511 Preclinical
CHEMBL3085291 9.05 Kd 0.8913 Preclinical
Distribution

pChEMBL Value Distribution

20
5.0
43
5.5
47
6.0
56
6.5
49
7.0
52
7.5
39
8.0
37
8.5
9
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

FORMOTEROL
CHEMBL1256786
Approved 2001
SALMETEROL
CHEMBL1263
Approved 1994
ESMOLOL
CHEMBL768
Approved 1986
BETAXOLOL
CHEMBL423
Approved 1985
LABETALOL
CHEMBL429
Approved 1984
ATENOLOL
CHEMBL24
Approved 1981
TIMOLOL
CHEMBL499
Approved 1978
METOPROLOL
CHEMBL13
Approved 1978
PROPRANOLOL
CHEMBL27
Approved 1967
EPINEPHRINE
CHEMBL679
Approved 1965
ISOPROTERENOL
CHEMBL434
Approved 1956
NOREPINEPHRINE
CHEMBL1437
Approved 1950
Assay Landscape

Assay Landscape

169
Total Assays
263
Tested Compounds
2
Assay Types
Binding — 97 assays, 263 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 88 209 6.8
tissue-based format 6 49 7.8
assay format 2 5 5.7
organism-based format 1 0
Functional — 72 assays, 97 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 47 82 6.3
tissue-based format 20 15 7.5
organism-based format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine